Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.

Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.

Item
http://www.wikidata.org/entity/Q41824705
Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance.Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers.The role of glucocorticoid receptor in prostate cancer progression: from bench to bedside.Targeting AXL overcomes resistance to docetaxel therapy in advanced prostate cancer.Microtubule-associated protein tau is associated with the resistance to docetaxel in prostate cancer cell linesMolecular Mechanisms of Enzalutamide Resistance in Prostate Cancer.Inhibiting autophagy overcomes docetaxel resistance in castration-resistant prostate cancer cells.Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches.Measuring glucocorticoid receptor expression in vivo with PET.
P2860

Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.

Item
http://www.wikidata.org/entity/Q41824705
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
@en
type
label
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
@en
prefLabel
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932
P356
P1433
P1476
Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P932